Skip to content

LATEST NEWS

Alpha Cognition Inc. Announces Granted EU Patents and Orphan Drug Designation for its Progranulin Platform

May 13, 2020

Vancouver, BC (Canada) May 12, 2020 –Alpha Cognition Inc. (ACI) [formerly Neurodyn Cognition], a clinical stage biotherapeutics company, announced today it has been granted two EU patents (EP2249861A1…

Read More...

Government provides tariff relief to importers of certain medical goods

May 12, 2020

Republished from the Department of Finance, Government of Canada. May 6, 2020 – The Government of Canada continues to take immediate, significant and decisive action to protect Canadians’…

Read More...

Clara Deacon appointed as Director of Communications and Marketing

May 8, 2020

The Prince Edward Island BioAlliance is pleased to announce the appointment of Clara Deacon as Director of Communications and Marketing. Clara will be responsible for leading the communications and marketing…

Read More...

Alpha Cognition Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer’s Therapy

April 30, 2020

April 30, 2020 – Alpha Cognition Inc. (ACI) [formerly Neurodyn Cognition] today announced that in a pre-Investigational New Drug (Pre-IND) meeting, the U.S. Food and Drug Administration (USFDA) agreed…

Read More...

Podcast: Interview with PEI BioAlliance CEO Rory Francis

April 28, 2020

Listen to the Growing Pains Podcast with Matt George & David Campbell as they interview Prince Edward Island BioAlliance CEO Rory Francis on the growth and success of…

Read More...

PEI bioscience industry answers the call to battle COVID-19

April 16, 2020
Zahra Merchant, pharmaceutical formulation scientist, holding BioVectra’s gel sanitizer

As essential service staff work long hours and families distance themselves from others by hunkering down in their homes, bioscience companies and their employees are flexing their research,…

Read More...
Scroll To Top